SABCS 2025: Delaying Disease Progression in HER2-positive Metastatic Breast Cancer and The Effect of Preoperative Breast MRI Staging on Local Regional Recurrence

HealthDay interviews Virginia Kaklamani, MD, DSc, Co-Director of the San Antonio Breast Cancer Symposium, about two potentially practice changing trials, and Isabelle Bedrosian, MD, FACS, of The University of Texas MD Anderson Cancer Center, about a new study on breast cancer MRI staging